School of Medicine
From driving cutting-edge research to bringing medical innovations to market, landing competitive awards and more, the faculty, staff and students at ÐÓ°ÉÊÓÆµ know how to make headlines.
Hero Type
Image
Molecular ‘brake’ in brain development could hold key to treating multiple sclerosis
Discovery led by Institute for Glial Sciences at ÐÓ°ÉÊÓÆµ suggests new path to regenerative therapies for MS
Recent News
Hero Type
Image
October 30, 2024
The system, devised by researchers at ÐÓ°ÉÊÓÆµ and Cleveland Clinic, better accounts for biological disadvantages that limit access to transplant for some patients
Researchers at ÐÓ°ÉÊÓÆµ and Cleveland Clinic have developed a new method that could poten...
Hero Type
Image
October 29, 2024
With the rise of digital health tools and abundant online resources, we live in an era where healthcare information is more accessible than ever. This information is essential to navigate one’s health journey, but without an understanding of complex data and medical jargon, test results may prompt p...
Hero Type
Image
October 25, 2024
As construction cranes for the Interdisciplinary Science and Engineering Building towered in the background, ÐÓ°ÉÊÓÆµ leadership, supporters and community partners took part in a ceremonial groundbreaking Wednesday evening for the project—a 189,000-square-foot, state-of-the-art facility ...
Hero Type
Image
October 25, 2024
Innovation Week, the annual celebration of ÐÓ°ÉÊÓÆµâ€™s innovative and entrepreneurial spirit, kicks off on Monday, Oct. 28.
Among the festivities will be the honoring of this year’s Faculty Distinguished Research Award winners. Established in 2013, the award is given annually ...
Hero Type
Image
October 24, 2024
Researchers at ÐÓ°ÉÊÓÆµ School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D).
Alzheimer’s disease is a brain disorder tha...
Hero Type
Image
October 22, 2024
The National Institutes of Health awarded a four-year, $2.6 million grant to researchers at ÐÓ°ÉÊÓÆµ to study how high blood-pressure drugs affect patients with chronic kidney disease (CKD).
More specifically, they want to study whether such medications increase the risk of k...
Hero Type
Image
October 18, 2024
Tian Liu, assistant professor of pathology at ÐÓ°ÉÊÓÆµ School of Medicine, was recently awarded a five-year, $630,595 National Institutes of Health (NIH) R01 grant to study the role of the CHCHD10 protein in Alzheimer’s disease.
This work is an example of the Cleveland Alzhei...
Hero Type
Image
October 17, 2024
Don't let your upcoming assignments scare you! Come see the KSL librarians in the Cramelot Cafe on Wednesday, October 30 from 5 - 6:30 p.m.
Librarians will be giving away pizza and answering any library-related or research questions you have to ensure that this semester is a success! Bring your app...
Hero Type
Image
October 16, 2024
Join members of the School of Medicine Enrollment Management team and representatives from the ÐÓ°ÉÊÓÆµ Benefits Office for an in-person presentation.
This session will be held Wednesday, Oct. 23, from 3 to 4 p.m. in Biomedical Research Building, Room 105.
Attendees will dis...
Hero Type
Image
October 15, 2024
With a new four-year, $1.3 million grant from the U.S. Department of Veterans Affairs, researchers at ÐÓ°ÉÊÓÆµ are investigating a new approach to treat acute myeloid leukemia (AML) in military veterans.
AML is the most common form of blood cancer in adults, and many patien...